Highlights and Quick Summary
- EPS (Diluted, from Cont. Ops) for the quarter ending June 30, 2023 was $-0.456 (a -8.89% decrease compared to previous quarter)
- Year-over-year quarterly EPS (Diluted, from Cont. Ops) increased by 320.46%
- Annual EPS (Diluted, from Cont. Ops) for 2022 was $-1.55 (a -3.73% decrease from previous year)
- Annual EPS (Diluted, from Cont. Ops) for 2021 was $-1.61 (a 123.61% increase from previous year)
- Annual EPS (Diluted, from Cont. Ops) for 2020 was $-0.72 (a -40.0% decrease from previous year)
- Twelve month EPS (Diluted, from Cont. Ops) ending June 30, 2023 was $-1.52 (a -3.24% decrease compared to previous quarter)
- Twelve month trailing EPS (Diluted, from Cont. Ops) increased by 9.19% year-over-year
Trailing EPS (Diluted, from Cont. Ops) for the last four month:
| 30 Jun '23 | 31 Mar '23 | 31 Dec '22 | 30 Sep '22 |
|---|---|---|---|
| $-1.52 | $-1.57 | $-1.55 | $-1.4 |
Visit stockrow.com/DRRX
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical EPS (Diluted, from Cont. Ops) of DURECT Corporation
Most recent EPS (Diluted, from Cont. Ops)of DRRX including historical data for past 10 years.Interactive Chart of EPS (Diluted, from Cont. Ops) of DURECT Corporation
DURECT Corporation EPS (Diluted, from Cont. Ops) for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $0.0 | $0.0 | – | – | – |
| 2022 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| 2021 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| 2020 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| 2019 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| 2018 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| 2017 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| 2016 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| 2015 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| 2014 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| 2013 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| 2012 | $0.0 | $0.0 | – | – | $0.0 |
Business Profile of DURECT Corporation
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic